Завантаження...

News

11.03.2019

Bacteriophages of the Human Gut

Scientists from University College Cork review the composition and physiological relevance of human gut bacteriophages

27.02.2019

WHO: Keep antibiotics working – limit their use this flu season

Antibiotics need to be used with care to preserve their effectiveness for when they are truly needed

24.02.2019

Phage Therapy: Beyond Antibacterial Action

Data obtained strongly suggest that phages may induce immunomodulatory effects which can be used in the clinic in phagotherapy

17.02.2019

Safety and efficacy of a bacteriophage cocktail in an in vivo model of sinusitis

Pseudomonas aeruginosa  phage cocktail in a sheep model of rhinosinusitis was able to decrease sinus pathogen biofilm. No safety concerns were noted

07.02.2019

Antimicrobial assessment of phage therapy of biofilm infection

Phage therapy constitutes a very promising approach in the control of topical microbial populations

25.01.2019

Bacteriophages could aid disinfection of drug-resistant bacteria in wastewater

A new study shows that these pathogenic bacteria can be killed cheaply and quickly by a combined treatment with sunlight and bacteria-killing viruses called bacteriophages

19.01.2019

Phage Studies in the USA in 2019

Two phage clinical trials will launch in the USA  in 2019. The trials will evaluate the safety, tolerability and efficacy of experimental bacteriophage therapy  in people with Crohn's disease and VADs infected by resistant S. aureus

11.01.2019

Phage Therapy one of the Top 10 Drug Discovery Trends to Watch in 2019

Researchers from across disciplines at Charles River discuss which trends they expect will propel the development of novel therapeutics forward this year. Phage Therapy one of the Top 10 Drug Discovery Trends to Watch in 2019

05.01.2019

Microbiome Movement - Drug Development Summit Europe 2019

The 3rd Microbiome Movement – Drug Development Europe (28-30 January 2019) returns as the industry-defining forum to help discover, develop and deliver the next generation of microbiome-based therapeutic and diagnostic candidates to market